Crossref


1. Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients

- Tomoyuki Suehiro

- Hisamitsu Miyaaki

- Yasuko Kanda

- Hidetaka Shibata

- Takuya Honda

- Eisuke Ozawa

- Satoshi Miuma

- Naota Taura

- Kazuhiko Nakao

2. Inhibitory Effect on the Hepatitis B Cells through the Regulation of miR-122-MAP3K2 signal pathway

- SONGLIN CHEN

- LEI YANG

- AIPING PAN

- SILIANG DUAN

- MINGFEN LI

- PING LI

- JINGJING HUANG

- XINGXIN GAO

- XIAOQI HUANG

- YINGHUI LIN

5. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC

- Muhammad Adeel Rana

- Bushra Ijaz

- Muhammad Daud

- Sommyya Tariq

- Tariq Nadeem

- Tayyab Husnain

10. miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling

- Hossein Sendi

- Ivy Mead

- Meimei Wan

- Marjan Mehrab-Mohseni

- Kenneth Koch

- Anthony Atala

- Herbert L. Bonkovsky

- Colin E. Bishop

- Matias A. Avila

11. MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3

- Gang Xu

- Fang Yang

- Cui-Ling Ding

- Jing Wang

- Ping Zhao

- Wen Wang

- Hao Ren

12. Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus

- Dongni Gao

- Aixia Zhai

- Jun Qian

- Aimei Li

- Yujun Li

- Wuqi Song

- Hong Zhao

- Xin Yu

- Jing Wu

- Qingmeng Zhang

- Wenping Kao

- Lanlan Wei

- Fengmin Zhang

- Zhaohua Zhong

13. The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model

- Yiyi Hu

- Guoping Du

- Guohua Li

- Xuetao Peng

- Zhiqiao Zhang

- Yingji Zhai

15. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells

- Jialin He

- Kai Zhao

- Lu Zheng

- Zhizhen Xu

- Wei Gong

- Shan Chen

- Xiaodong Shen

- Gang Huang

- Min Gao

- Yijun Zeng

- Yan Zhang

- Fengtian He

16. Antitumor function of microRNA-122 against hepatocellular carcinoma

- Kazuhiko Nakao

- Hisamitsu Miyaaki

- Tatsuki Ichikawa

17. miR‐122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA

- Hossein Sendi

- Marjan Mehrab‐Mohseni

- David M. Foureau

- Sriparna Ghosh

- Tracy L. Walling

- Nury Steuerwald

- Philippe J. Zamor

- Keith J. Kaplan

- Carl Jacobs

- William A. Ahrens

- Mark W. Russo

- Mark G. Clemens

- Laura W. Schrum

- Herbert L. Bonkovsky

20. Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis

- Hossein Sendi

- Mostafa Yazdimamaghani

- Mengying Hu

- Nikhila Sultanpuram

- Jie Wang

- Amber S. Moody

- Ellie McCabe

- Jiajie Zhang

- Amanda Graboski

- Liantao Li

- Juan D. Rojas

- Paul A. Dayton

- Leaf Huang

- Andrew Z. Wang

21. miR-125b inhibits hepatitis B virus expression in vitro through targeting of the SCNN1A gene

- Zhenzhen Zhang

- Juan Chen

- Yin He

- Xue Zhan

- Ruiqiu Zhao

- Yanfeng Huang

- Hongmei Xu

- Zhaomin Zhu

- Quanbo Liu